triclabendazole sulfoxide has been researched along with praziquantel in 1 studies
| Studies (triclabendazole sulfoxide) | Trials (triclabendazole sulfoxide) | Recent Studies (post-2010) (triclabendazole sulfoxide) | Studies (praziquantel) | Trials (praziquantel) | Recent Studies (post-2010) (praziquantel) |
|---|---|---|---|---|---|
| 30 | 1 | 16 | 4,625 | 423 | 1,685 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barakat, R; Chollet, J; Diab, T; El Ela, NA; El Komy, E; El Lakkany, N; Keiser, J; Utzinger, J | 1 |
1 other study(ies) available for triclabendazole sulfoxide and praziquantel
| Article | Year |
|---|---|
Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
Topics: Animals; Anthelmintics; Benzimidazoles; Disease Models, Animal; Feces; Female; Liver; Male; Mesenteric Veins; Mice; Parasite Egg Count; Praziquantel; Schistosoma mansoni; Schistosomiasis mansoni; Sulfoxides; Triclabendazole | 2006 |